For updates visit

EMKAY - Morning Meeting Notes

Friday, April 13, 2007

Jet Airways has signed a deal to buy all equity shares of Air Sahara for a lumpsum payment of Rs 1,450 crore. Harish Salve, the legal representative of Jet, said Rs 400 crore has to be paid to Air Sahara before April 20, 2007. –BS

Lupin on Thursday said it has received US Food and Drug Administration approval for Suprax Cefixime, an antibiotic, which would help in increasing its share in the paediatric market. –ET

After commissioning its $11 million switch gear manufacturing facility in China, construction major Larsen & Toubro is all set to start operations at its other two plants in the neighbouring
country by the end of this quarter. –ET

Ballarpur Industries reported a net profit of Rs 64.06 crore for the third quarter ended March 31, 2007 as against Rs 52.52 crore in Q3FY06. –BS

Gail India and Indian Oil Corporation have entered into an understanding for formation of a joint venture company for city gas distribution projects in West Bengal. –BS

Titan Biotech has recently bagged export orders of over $1,30,000 or export of its products. The demand for company’s product is increasing domestically as well as overseas and the company is growing rapidly at 25 per cent per annum. –BL

Lanco Infratech said two hydro projects of Vamshi Industrial Power Ltd, a subsidiary of the company, were registered as Clean Development Mechanism Projects with United Nations Framework Convention on Climate Change. The registration would help the projects to trade in Certified Emission Reductions. –BL

US-based real estate developer Royal Indian Raj International Corporation (RIRIC) will invest $6 billion in India over the next seven years to develop hotels and residential resorts. –BS

Treating India as the most important market after China in Asia Pacific, Starwood Hotels & Resorts is targeting to double properties from the current 19 over the next five years. –BS


Download full report Here

Posted by FR at 9:41 PM  

0 comments:

Post a Comment

IMPORTANT DISCLAIMER

Investment in equity shares has its own risks. Sincere efforts have been made to present the right investment perspective.The information contained herein is based on analysis and up on sources that we consider reliable. I, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and I am not responsible for any loss incurred based upon it.& take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations given in this blog.